Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ESC 23: Economic Burden of CVD in the EU
Author(s): Ramón Luengo-Fernández Added: 2 years ago
ESC 2023 — Dr Ramón Luengo-Fernández (University of Oxford, UK) joins us on-site to discuss the findings from a registry which aimed to analyse the economic burden of cardiovascular disease within the EU. This was the first study to utilise Europe-wide patient registries and included the costs of long-term social care. Results from the registry found that cardiovascular disease cost the EU €282… View more

Guidelines & Statements
Added: 6 months ago Source:  Radcliffe CVRM
AUTHOR: Liam ONeillWhile elevated systolic blood pressure variability (SBPV) is a known risk factor for adverse health outcomes, new research published in the European Heart Journal suggests that the change in SBPV over time is also a critical prognostic indicator. The study found that an increase in visit-to-visit SBPV over a 10-year period was significantly associated with a higher risk of… View more

Cardiovascular Renal Metabolic

Heart Failure
Heart Disease in Pregnancy: Maternal and Neonatal Risk
Author(s): Rofila Dita Karmia , Mefri Yanni , Yusrawati , et al Added: 2 weeks ago

Electrophysiology & Arrhythmia

Heart Failure
ESC Scientific Statement: Extreme Heat Poses Significant Cardiovascular Risk
Added: 5 months ago Source:  Radcliffe Cardiology
With global temperatures rising and heatwaves becoming more frequent and intense, the impact on public health is a growing concern. A new scientific statement from the European Society of Cardiology (ESC) and several of its constituent bodies highlights the significant risk that extreme heat poses to cardiovascular health, particularly for the elderly and individuals with pre-existing… View more

Demographic

Electrophysiology & Arrhythmia
High-Dose Flu Vaccine Linked to Reduced Cardiovascular Hospitalisations in Older Adults
Added: 4 months ago Source:  Radcliffe Cardiology
A prespecified secondary analysis of the DANFLU-2 trial suggests that a high-dose inactivated influenza vaccine (HD-IIV) may offer greater protection against cardiovascular-related hospitalisations in older adults compared to a standard-dose vaccine (SD-IIV).¹˒² While the trial’s primary endpoint was not met, these exploratory findings point to a potential benefit in reducing the burden of… View more

Cardiovascular Renal Metabolic

Demographic
The aim of the Primary Care Cardiovascular Society (PCCS) is to provide activities which benefit the community of healthcare practitioners who deliver care to people with, or at risk of, cardiovascular disease. We support, educate and mentor healthcare practitioners to develop their knowledge and skills. We offer a programme of educational events throughout the year as well as offering our… View more
CardioNerds @AHA23: SELECT: Effects of Semaglutide on Heart Disease & Stroke in Obese Patients
Author(s): A Michael Lincoff , Ahmed Ghoneem Added: 2 years ago
AHA 2023 - Investigator, Dr A Michael Lincoff (Cleveland Clinic, US) is interviewed by Dr Ahmed Ghoneem (UPMC Harrisburg, US), CardioNerds Ambassador, on the findings of the SELECT Trial (NCT03574597).SELECT is a randomised trial aiming to determine if semaglutide can reduce the risk of cardiovascular events in patients with overweight or obesity and prior cardiovascular disease. 17609 patients… View more

Guidelines & Statements

Prevention & Chronic Conditions
Importance of Testing for CKD Among Patients With Type 2 Diabetes
Author(s): Pam Taub , Nikolaus Marx Added: 1 year ago
RP-UN-CAR-GB-0166 / June 2024This programme features a compelling discussion between two distinguished experts, Prof Pam Taub (University of California, San Diego, US) and Prof Nikolaus Marx (University Hospital RWTH, Aachen, DE), chairperson responsible for the most recent ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes. Together, they delve into a critical… View more

Guidelines & Statements

Prevention & Chronic Conditions
Yutao Guo
Prof Yutao Guo is currently working at theDepartment of Cardiology at the Medical School of Chinese PLA, Chinese PLA General Hospital, Beijing, China. Her research interests include clinical epidemiology and cardiovascular disease prevention. Prof Guo led the ChiOTEAF registry, which included over 10 million participants and aimed to study the ethnic differences in the disease burden of atrial… View more
ICOS-CORE Whitepaper Calls for Rigorous Evidence to Support Cardio-oncology Rehabilitation
Added: 5 months ago Source:  Radcliffe Cardiology
A new whitepaper from the International Cardio-Oncology Society (ICOS) CORE working group outlines a critical roadmap for advancing the cardiovascular care of cancer survivors. Published in the European Heart Journal, the paper reviews the current evidence for cardio-oncology rehabilitation and exercise (CORE) programmes and sets new standards for future research to address significant knowledge… View more

CV Disease in Special Populations

Guidelines & Statements